7,572
Views
536
CrossRef citations to date
0
Altmetric
Original Research Articles

Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood

, , &
Article: 23743 | Received 01 Apr 2014, Accepted 02 Nov 2014, Published online: 26 Mar 2014

References

  • Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004; 32: D109–11.
  • Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005; 122: 6–7.
  • Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011; 108: 5003–8.
  • Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9.
  • Schipper H, Maes O, Chertkow H, Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio. 2007; 1: 263–74. [PubMed Abstract] [PubMed CentralFull Text].
  • Vaz C, Ahmad HM, Sharma P, Gupta R, Kumar L, Kulshreshtha R et al. Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics. 2010; 11: 288.
  • Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L, Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY). 2012; 4: 590–605. [PubMed Abstract].
  • Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010; 102: 1174–9.
  • Coleman BM, Hanssen E, Lawson VA, Hill AF. Prion-infected cells regulate the release of exosomes with distinct ultrastructural features. FASEB J. 2012; 26: 4160–73.
  • Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012; 40: 10937–49.
  • Cheng L, Quek CY, Sun X, Bellingham SA, Hill AF. The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet. 2013; 4: 150.
  • Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int. 2013. Epub ahead of print.
  • Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012; 7: e30679.
  • Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H et al. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PLoS One. 2013; 8: e75184.
  • Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol. 2007; 211: 582–90.
  • Kirschner MB, Edelman JJ, Kao SC, Vallely MP, van Zandwijk N, Reid G. The impact of hemolysis on cell-free microRNA biomarkers. Front Genet. 2013; 4: 94. [PubMed Abstract] [PubMed CentralFull Text].
  • Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10: e1001450.
  • Lopez-Corral L, Mateos MV, Corchete LA, Sarasquete ME, de la Rubia J, de Arriba F et al. Genomic analysis of high-risk smoldering multiple myeloma. Haematologica. 2012; 97: 1439–43.
  • Xu S, Yu B, Chertkow H, Wang E, Schipper H. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging. 2007; 28: 1795–809.
  • Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013; 8: e64795.
  • Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012; 7: e41561.
  • Yu D, dos Santos CO, Zhao G, Jiang J, Amigo JD, Khandros E et al. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev. 2010; 24: 1620–33.
  • Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, Bilbao-Cortes D et al. The miR-144/451 locus is required for erythroid homeostasis. J Exp Med. 2010; 207: 1351–8.
  • Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008; 451: 1125–9.
  • Sonntag KC, Woo TU, Krichevsky AM. Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol. 2012; 235: 427–35.
  • Mellios N, Huang HS, Grigorenko A, Rogaev E, Akbarian S. A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet. 2008; 17: 3030–42.
  • Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Regulation of miRNA expression during neural cell specification. Eur J Neurosci. 2005; 21: 1469–77.
  • Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB. Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS. 2013; 10: 4.
  • Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011; 29: 341–5.
  • Patel RS, Jakymiw A, Yao B, Pauley BA, Carcamo WC, Katz J et al. High resolution of microRNA signatures in human whole saliva. Arch Oral Biol. 2011; 56: 1506–13.
  • Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15: 5473–7.
  • Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S et al. Exosome can prevent RNase from degrading microRNA in feces. J Gastrointest Oncol. 2011; 2: 215–22. [PubMed Abstract] [PubMed CentralFull Text].
  • Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513–8.
  • Gao X, Zhang R, Qu X, Zhao M, Zhang S, Wu H et al. MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma. Leuk Res. 2012; 36: 1505–9.
  • Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H et al. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol. 2013; 139: 223–9.
  • Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008; 14: 27–41. [PubMed Abstract].